Mr. Speaker, there is no question that the purpose of drug patent protection is there to protect intellectual property and should not be abused to expand protection beyond the period which is already prescribed.
I have said when appearing before a committee in the other place that we are quite prepared at an appropriate time to look at the regulations, the way in which they are working, to ensure that there is no abuse.